Carbohydrate restriction (with or without additional dietary cholesterol provided by eggs) reduces insulin resistance and plasma leptin without modifying appetite hormones in adult men

Nutrition Research

Volumn 29, Issue 4, 2009, Pages 262-268

  Ratliff, Joseph ^a   Mutungi, Gisella ^a   Puglisi, Michael J ^a   Volek, Jeff S ^a   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Carbohydrate restriction; Eggs; Leptin; Overweight men; Satiety hormones

Indexed keywords

CHOLESTEROL; GHRELIN; GLUCOSE; INSULIN; LEPTIN; PLACEBO;

ADULT; AGED; APPETITE; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CARBOHYDRATE INTAKE; CHOLESTEROL INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; EGG; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SATIETY; SATISFACTION; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

ADULT; AGED; ANALYSIS OF VARIANCE; APPETITE; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; CHOLESTEROL, DIETARY; DIET, CARBOHYDRATE-RESTRICTED; DIET, REDUCING; DIETARY PROTEINS; EGGS; ENERGY INTAKE; GHRELIN; HORMONES; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; PANCREATIC POLYPEPTIDE; PEPTIDE YY; SATIATION;

EID: 65349084973     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2009.03.007     Document Type: Article

References (62)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
2. Veech R.L. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70 (2004) 309-319
3. Volek J.S., Sharman M.J., Love D.M., Avery N.G., Gomez A.L., Scheett T.P., et al. Body composition and hormonal responses to a carbohydrate-restricted diet. Metabolism 51 (2002) 864-870
4. Yancy W.S., Olsen M.K., Guyton J.R., Bakst R.P., and Westman E.C. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med 140 (2004) 769-777
5. Layman D.K., and Baum J.I. Dietary protein impact on glycemic control during weight loss. J Nutr 134 (2004) 968S-973S
6. Layman D.K., Boileau R.A., Erickson D.J., Painter J.E., Shiue H., Sather C., et al. A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J Nutr 133 (2003) 411-417
7. Volek J., Sharman M., Gómez A., Judelson D., Rubin M., Watson G., et al. Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women. Nutr Metab (Lond) 1 (2004) 13
8. Sharman M.J., Gomez A.L., Kraemer W.J., and Volek J.S. Very low-carbohydrate and low-fat diets affect fasting lipids and postprandial lipemia differently in overweight men. J Nutr 134 (2004) 880-885
9. Volek J.S., and Sharman M.J. Cardiovascular and hormonal aspects of very-low-carbohydrate ketogenic diets. Obes Res Suppl 2 (2004) 115S-123S
10. Volek J.S., and Feinman R.D. Carbohydrate restriction improves the features of metabolic syndrome. Metabolic syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) 2 (2005) 31
11. Wood R.J., Volek J.S., Liu Y., Shachter N.S., Contois J.H., and Fernandez M.L. Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL and HDL subfraction distribution and size in overweight men. J Nutr 136 (2005) 384-389
12. Kohrt W.M., Kirwan J.P., Staten M.A., Bourey R.E., King D.S., and Holloszy J.O. Insulin resistance in aging is related to abdominal obesity. Diabetes 42 (1993) 273-281
13. Jensen M.D., Caruso M., Heiling V., and Miles J.M. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38 (1989) 1595-1601
14. Zammit V.A. Insulin stimulation of hepatic triacylglycerol secretion in the insulin-replete state: implications for the etiology of peripheral insulin resistance. Ann N Y Acad Sci 967 (2002) 52-65
15. Johnston C.S., Tjonn S.L., and Swan P.D. High-protein, low-fat diets are effective for weight loss and favorably alter biomarkers in healthy adults. J Nutr 134 (2004) 586-591
16. Herron K.L., Vega-Lopez S., Ramjiganesh T., Conde K., Shachter N., and Fernandez M.L. Men classified as hypo- or hyper-responders to a dietary cholesterol challenge exhibit differences in lipoprotein metabolism. J Nutr 133 (2003) 1036-1042
17. Greene C.M., Zern T.L., Wood R., Shresthra S., Aggarwal D., Sharman M., et al. Maintenance of the LDL cholesterol:HDL cholesterol ratio in an elderly population given a dietary cholesterol challenge. J Nutr 135 (2005) 2793-2798
18. Wood R.J., Fernandez M.L., Sharman M.J., Silvestre R., Greene C.M., Zern T.L., et al. Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk. Metabolism 56 (2007) 58-67
19. Esrey K.L., Joseph L., and Grover S.A. Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study. J Clin Epidemiol 49 (1996) 211-216
20. Vander Wal J.S., Marth J.M., Khosla P., Jen K.L., and Dhurandhar N.V. Short-term effect of eggs on satiety in overweight and obese subjects. J Am Coll Nutr 24 (2005) 510-515
21. Ratliff J.C., Mutungi G., Puglisi M.J., Volek J.S., and Fernandez M.L. Eggs modulate the inflammatory response to carbohydrate restricted diets in overweight men. Nutr Metab (Lond) 5 (2008) 6
22. Mutungi G., Ratliff J., Puglisi M., Torres-Gonzalez M., Vaishnav U., Leite J.O., et al. Dietary cholesterol from eggs increases plasma HDL cholesterol in overweight men consuming a carbohydrate-restricted diet. J Nutr 138 (2008) 272-276
23. Kaplan R.C., Ho G.Y., Xue X., Rajpathak S., Cushman M., Rohan T.E., et al. Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Biomarkers Prev 16 (2007) 1291-1293
24. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
25. Sharman M.J., Kraemer W.J., Love D.M., Avery N.G., Gomez A.L., Scheett T.P., et al. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr 132 (2002) 1879-1885
26. Volek J.S., Sharman M.J., Gomez A.L., Scheett T.P., and Kraemer W.J. An isoenergetic very low carbohydrate diet improves serum HDL cholesterol and triacylglycerol concentrations, the total cholesterol to HDL cholesterol ratio and postprandial pipemic responses compared with a low fat diet in normal weight, normolipidemic women. J Nutr 133 (2003) 2756-2761
27. Bagdade J.D., Bierman E.L., and Porte Jr. D. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 46 (1967) 1549-1557
28. Reaven G.M., Abbasi F., Bernhart S., Coulston A., Darnell B., Dashti N., et al. Insulin resistance, dietary cholesterol, and cholesterol concentration in postmenopausal women. Metabolism 50 (2001) 594-597
29. Sims E.A., Danforth Jr. E., Horton E.S., Bray G.A., Glennon J.A., and Salans L.B. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 29 (1973) 457-496
30. Volek J.S., Sharman M.J., and Forsythe C.E. Modification of lipoproteins by very low-carbohydrate diets. J Nutr 135 (2005) 1339-1342
31. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
32. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334 (1996) 292-295
33. Soderberg S., Ahren B., Stegmayr B., Johnson O., Wiklund P.G., Weinehall L., et al. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 30 (1999) 328-337
34. Wallace A.M., McMahon A.D., Packard C.J., Kelly A., Shepherd J., Gaw A., et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 104 (2001) 3052-3056
35. Enriori P.J., Evans A.E., Sinnayah P., and Cowley M.A. Leptin resistance and obesity. Obesity 14 (2006) 254S-258S
36. Reseland J.E., Haugen F., Hollung K., Solvoll K., Halvorsen B., Brude I.R., et al. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 42 (2001) 743-750
37. Mori T.A., Burke V., Puddey I.B., Shaw J.E., and Beilin L.J. Effect of fish diets and weight loss on serum leptin concentration in overweight, treated-hypertensive subjects. J Hypertens 22 (2004) 1983-1990
38. Dubuc G.R., Phinney S.D., Stern J.S., and Havel P.J. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 47 (1998) 429-434
39. Flier J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116 (2004) 337-350
40. Mars M., de Graaf C., de Groot L.C., and Kok F.J. Decreases in fasting leptin and insulin concentrations after acute energy restriction and subsequent compensation in food intake. Am J Clin Nutr 81 (2005) 570-577
41. Weigle D.S., Breen P.A., Matthys C.C., Callahan H.S., Meeuws K.E., Burden V.R., et al. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr 82 (2005) 41-48
42. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 285 (2001) 2486-2497
43. Accurso A., Bernstein R.K., Dahlqvist A., Draznin B., Feinman R.D., Fine E.J., et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond) 5 (2008) 9
44. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
45. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
46. Tschop M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., and Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709
47. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346 (2002) 1623-1630
48. Weigle D.S., Cummings D.E., Newby P.D., Breen P.A., Frayo R.S., Matthys C.C., et al. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab 88 (2003) 1577-1586
49. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120 (2001) 337-345
50. Gelling R.W., Overduin J., Morrison C.D., Morton G.J., Frayo R.S., Cummings D.E., et al. Effect of uncontrolled diabetes on plasma ghrelin concentrations and ghrelin-induced feeding. Endocrinology 145 (2004) 4575-4582
51. Foster-Schubert K.E., Overduin J., Prudom C.E., Liu J., Callahan H.S., Gaylinn B.D., et al. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J Clin Endocrinol Metab 93 (2008) 1971-1979
52. Adrian T.E., Bloom S.R., Bryant M.G., Polak J.M., Heitz P.H., and Barnes A.J. Distribution and release of human pancreatic polypeptide. Gut 17 (1976) 940-944
53. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., and Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89 (1985) 1070-1077
54. le Roux C.W., Batterham R.L., Aylwin S.J., Patterson M., Borg C.M., Wynne K.J., et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147 (2006) 3-8
55. Batterham R.L., le Roux C.W., Cohen M.A., Park A.J., Ellis S.M., Patterson M., et al. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 88 (2003) 3989-3992
56. Batterham R.L., Cohen M.A., Ellis S.M., le Roux C.W., Withers D.J., Frost G.S., et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349 (2003) 941-948
57. Tovar S.A., Seoane L.M., Caminos J.E., Nogueiras R., Casanueva F.F., and Dieguez C. Regulation of peptide YY levels by age, hormonal, and nutritional status. Obes Res 12 (2004) 1944-1950
58. Wynne K., Stanley S., and Bloom S. The gut and regulation of body weight. J Clin Endocrinol Metab 89 (2004) 2576-2582
59. Essah P.A., Levy J.R., Sistrun S.N., Kelly S.M., and Nestler J.E. Effect of macronutrient composition on postprandial peptide YY levels. J Clin Endocrinol Metab 92 (2007) 4052-4055
60. Blundell J.E., and Hill A.J. Paradoxical effects of an intense sweetener (aspartame) on appetite. Lancet 1 (1986) 1092-1093
61. de Castro J.M. Macronutrient relationships with meal patterns and mood in the spontaneous feeding behavior of humans. Physiol Behav 39 (1987) 561-569
62. Espelund U., Hansen T.K., Orskov H., and Frystyk J. Assessment of ghrelin. APMIS Suppl (2003) 140-145